Business
Steriwave receives regulatory approval in Mexico
Steriwave receives regulatory approval in Mexico.
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n \n \n \n \n \n 12 December 2022\n \n \n \n Ondine Biomedical Inc.\n \n \n \n \n \n \n \n \n (\"Ondine Biomedical\", \"Ondine\" or the \"Company\")\n \n \n \n \n \n \n Steriwave receives regulatory approval in Mexico\n \n \n \n \n Photodisinfection kills all types of pathogens, including viruses, bacteria and fungi without using antibiotics\n \n \n \n \n \n \n Ondine Biomedical Inc. (LON:OBI): Mexico's Health Authority (COFEPRIS) has approved the sale and use of Ondine Biomedical's Steriwave™ photodisinfection technology, which eliminates nasal pathogens that can cause healthcare-associated infections (HAIs). \n \n \n \n \n \n The large and growing Mexican healthcare market is of strategic interest to Ondine.\n Mexico's healthcare system provides coverage to its 129 million citizens through a combination of public and private entities.\n The private hospitals and medical facilities serve a large domestic market, together with up to 1 million foreign medical tourists a year-a market estimated to be worth US$6.75 billion in 2021.[1]\n \n \n \n \n \n Carolyn Cross, CEO of Ondine Biomedical, said:\n \n \n \"With significant global backlogs and high costs of various types of medical procedures, medical tourism is likely to be on the rise over the coming years, as foreign medical tourists seek state of the art medical services at affordable prices. The Mexican healthcare market is of strategic interest to our company and is of personal interest to me. I am thrilled to bring our technology to this important market and to help Mexican healthcare professionals better protect patients from the growing antimicrobial resistance threat.\n \n \n \n \n \n \"The great advantage of our photodisinfection therapy is that it not only spares patients the trauma of an infection, but it can also reduce patient waiting lists by reducing hospital readmissions rates and decreasing the average length of stay in hospital.\"\n \n \n \n \n \n Ondine is presently focused on commercialising its Steriwave™ nasal photodisinfection, which eliminates infection-causing bacteria, viruses, and fungi from patients' noses in minutes to prevent HAIs. Disinfection of the nose is recommended prior to surgery as pathogens in a patient's nasal cavities are a major cause of surgical site infections (SSIs).[2] A patient with a...